The WCIRDC is an excellent opportunity to meet with globally recognized medical leaders, clinicians, and scientists who present and share their knowledge. The WCIRDC is designed to evaluate both clinical and basic science aspects of insulin resistance, obesity, diabetes, and CVD.  It elevates many metabolic systems and their relationships, such as energy metabolism, fat cell, beta cell, gut, and the brain.

​

Clinical topics may include aspects of insulin resistance, inflammation and its relationship to obesity, diabetes, dyslipidemia, hypertension, and cardiovascular disease, as well as other abnormalities like endothelial and vascular dysfunction, PCOS, gonadal dysfunction, fatty liver disease, sleep disorder, and related cancers.  The Congress also focuses on multi-hormonal obesity, fat cell incretin and gut hormone contributions to energy balance, and its relationship to the circadian rhythm as it relates to these metabolic mechanisms.

​

The WCIRDC achieves a great balance between clinical practice and research, by utilizing the state-of-the-art approach:

“Exploring New Frontiers in Metabolism -Tomorrow’s Clinical Science Today” 

Please take advantage of these great CME funding opportunities. If you’d like more information or have any questions please contact us at:

​

818-342-1889 or info@tmioa.com

​